ArticleTranslational lung cancer research2025
Impact of coronavirus disease 2019 on surgery in patients with early-stage lung cancer: the COVIDLungSurg prospective cohort study.
Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05684549 (Effects of Coronavirus Infection), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effects of Coronavirus Infection (COVID-19) on the Timing and Prognosis of Radical Surgery in Patients With Early-stage Lung Cancer
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Previous studies found that preoperative coronavirus disease 2019 (COVID-19) was associated with higher risk of postoperative complications. A seven-to-eight week delay of surgery was recommended for patients with newly diagnosed COVID-19. However, given the widespread vaccination and less virulent variant, the timing of surgery after COVID-19 requires further evaluation. This study was conducted to investigate the impact of COVID-19 on early-stage lung cancer patients undergoing surgery. Methods: We conducted this prospective cohort study of COVID-19 lung surgery (COVIDLungSurg) in five hospitals in China between January 2023 and April 2024. Early-stage lung cancer patients who underwent surgery were included in this study. The primary outcome was the rate of postoperative complication within the first postoperative 30 days. The secondary outcomes included total length of hospital stay, postoperative stay, and 30-day mortality. Adjusted analyses were performed using propensity score matching and logistic regression models. This study was registered at ClinicalTrials.gov (NCT05684549). Results: Of the 1,734 patients included in our study, 1,496 had preoperative COVID-19. A total of 1,538 patients were fully vaccinated against COVID-19. The rate of postoperative complication was 9.5% (165/1,734) in all the included patients, with no significant difference in patients with and without history of COVID-19 [9.2% (137/1,496) Conclusions: In the Omicron predominant era, preoperative COVID-19 was not associated with higher risk of postoperative complications in early-stage lung cancer patients. The time between COVID-19 infection and surgery was not associated with postoperative complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.